Atai Life Sciences N.V. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ATAI Nasdaq 2830 www.atai.life

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Atai Life Sciences N.V.

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial - Mar 14th, 2025 3:40 pm
atai Life Sciences Announces First Patient Dosed in Elumina, the Phase 2 Clinical Trial of VLS-01 for Treatment-Resistant Depression - Mar 11th, 2025 11:00 am
atai Life Sciences Announces Completion of Enrollment in Phase 2b Clinical Trial Evaluating BPL-003 for Treatment-Resistant Depression - Mar 5th, 2025 12:00 pm
Atai Life Sciences N.V. (ATAI): Among the Best Psychedelic Stocks to Buy in 2025 - Mar 1st, 2025 4:08 pm
Psychedelic: GH Research, Compass Pathways report earnings results - Feb 28th, 2025 4:30 pm
atai Life Sciences to Participate in the TD Cowen 45th Annual Health Care Conference - Feb 24th, 2025 9:10 pm
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares - Feb 20th, 2025 12:00 pm
atai Life Sciences Announces Pricing of Public Offering of Common Shares - Feb 13th, 2025 3:47 am
atai Life Sciences Announces Proposed Public Offering of Common Shares - Feb 12th, 2025 9:01 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Feb 3rd, 2025 1:24 pm
Atai Life Sciences And 2 Other Promising Penny Stocks On US Exchanges - Jan 31st, 2025 1:05 pm
atai Life Sciences Announces Positive Topline Results from Beckley Psytech’s BPL-003 (intranasal 5-MeO-DMT benzoate) Phase 2a Open-Label Study for Alcohol Use Disorder - Jan 28th, 2025 12:00 pm
atai Life Sciences Announces Key Leadership Appointments as it Advances its Pipeline of Novel Psychedelic Therapeutics for Mental Health - Jan 10th, 2025 12:00 pm
US Penny Stocks To Consider In December 2024 - Dec 30th, 2024 1:12 pm
Oxbridge Re Holdings Among 3 US Penny Stocks To Watch - Nov 19th, 2024 1:04 pm
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Nov 13th, 2024 1:00 pm
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer - Nov 11th, 2024 12:30 pm
374Water And 2 Other Promising US Penny Stocks To Watch - Oct 21st, 2024 7:07 pm
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 15th, 2024 12:00 pm
atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - Sep 4th, 2024 11:00 am